NEU.AX - Neuren Pharmaceuticals Limited

ASX - ASX Delayed Price. Currency in AUD
Currency in AUD

Valuation Measures

Market Cap (intraday) 5111.19M
Enterprise Value 393.62M
Trailing P/E 35.81
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)7.95
Price/Book (mrq)4.51
Enterprise Value/Revenue 36.69
Enterprise Value/EBITDA 615.89

Trading Information

Stock Price History

Beta (3Y Monthly) 1.42
52-Week Change 3-59.12%
S&P500 52-Week Change 38.07%
52 Week High 32.9700
52 Week Low 30.9800
50-Day Moving Average 31.1590
200-Day Moving Average 31.2524

Share Statistics

Avg Vol (3 month) 394.36k
Avg Vol (10 day) 334.54k
Shares Outstanding 5100.17M
Float 58.52M
% Held by Insiders 1N/A
% Held by Institutions 1N/A
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 220/1
Last Split Date 3Nov 21, 2017

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Dec 31, 2018

Profitability

Profit Margin 21.97%
Operating Margin (ttm)41.56%

Management Effectiveness

Return on Assets (ttm)16.30%
Return on Equity (ttm)14.98%

Income Statement

Revenue (ttm)13.99M
Revenue Per Share (ttm)0.14
Quarterly Revenue Growth (yoy)2,117.10%
Gross Profit (ttm)7.89M
EBITDA 5.89M
Net Income Avi to Common (ttm)3.07M
Diluted EPS (ttm)0.0310
Quarterly Earnings Growth (yoy)4.80%

Balance Sheet

Total Cash (mrq)23.58M
Total Cash Per Share (mrq)0.23
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)13.50
Book Value Per Share (mrq)0.25

Cash Flow Statement

Operating Cash Flow (ttm)6.41M
Levered Free Cash Flow (ttm)12.42M